HOME >> BIOLOGY >> NEWS
Prostate Cancer's Aggressiveness May Be Predicted Early By The Ratio Of Free To Total PSA

The ratio of free to total prostate specific antigen (PSA) in a man's blood may predict at the time of diagnosis whether prostate cancer will be an aggressive, fast-growing disease or a non-aggressive, slow-growing type of cancer. This discovery by researchers at the National Institute on Aging (NIA) and colleagues at the Johns Hopkins University School of Medicine is published in the March, 1997, journal, Urology.

"The ability to differentiate between an aggressive and non-aggressive form of prostate cancer when the disease is diagnosed early puts the physician and patient in a better position to make decisions about treatment," says Dr. E. Jeffrey Metter, Medical Officer for the Baltimore Longitudinal Study of Aging (BLSA) of the NIA, one of the study's authors. "Physicians need a reliable way of distinguishing which cancers are serious, life-threatening tumors and which ones are not. The ratio of free to total PSA in sera may give physicians this information."

Today, physicians have effective means of diagnosing prostate cancer, but there is great debate about which treatment is best for a cancer diagnosed in the early stage-watchful waiting, surgery to remove a localized cancer, or radiation therapy. Each has advantages and disadvantages. Radiation and surgery may be associated, in some cases, with complications including impotence and incontinence. Watchful waiting means living with cancer and possibly missing an opportunity for cure.

"This preliminary study suggests that the free to total PSA ratio may be valuable to the physician at the time of cancer diagnosis to help in the choice of management since the more aggressive cancers need to be treated," says Metter.

PSA, an enzyme produced by the prostate gland, is found in high concentration in semen where it acts to liquefy the seminal fluid after ejaculation so that sperm can swim freely. Some PSA leaks into the blood stream from prostatic cells, more so in the presence of pros
'"/>

Contact: Suzanne Lewis
MillerM@31.nia.nih.gov
410-558-8114
NIH/National Institute on Aging
2-Apr-1997


Page: 1 2 3 4

Related biology news :

1. Prostate cancer test works as well for black men, study shows
2. Renowned Prostate Cancer Experts Present Latest Findings At UCSF Cancer Center Symposium
3. Seattle Researchers Zero In On Location Of Gene For Inherited Prostate Cancer; Gene Also Linked To Brain Cancer
4. Common Prostate Cancer: A Different Process Altogether?
5. Plant-Based Fat May Reduce Risk Of Prostate Cancer By Altering Testosterone Metabolism, UB Study Shows
6. Study Of Protein Reveals Two Different Prostate Cancers;One More Deadly Also Shows That Benign Prostate Hyperplasia Not A Precursor To Prostate Cancer
7. Penn Researchers Find Mutation In Prostate Cancer Gene
8. A New Molecular Marker For Prostate Cancer
9. Duration Of Pre-Clinical Prostate Cancer Based On Serial PSA Data From The VA Normative Aging Study
10. PSA Levels Mean More Extensive Prostate Disease In Older Men
11. New Test May Reduce Need For Some Prostate Cancer Biopsies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... August 15, 2019 , ... Deep Science Ventures ... Food and Agriculture practice, a new unit dedicated to building 100 companies over the ... raw materials and supply chains. , Deep Science Ventures was founded to create ...
(Date:8/14/2019)... ... ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research ... EDT to learn about two common imaging methods in NAFLD/NASH to aid with early ... diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided ...
(Date:8/9/2019)... ... , ... With a demand in healthcare to lower unneeded emergency room visits ... centers (UCC) in the coming years, according to a new report on the industry ... Centers , is a detailed look at the current state of these healthcare outlets, ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 10, 2019 , ... ... and technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local ... Group) and will educate viewers about how its technology facilitates laboratories to improve ...
(Date:6/11/2019)... Md. and ROANOKE, Va. (PRWEB) , ... June ... ... care optimized for microlearning engagement, and Carilion Clinic, a national leader in opioid ... the latest in virtual care. , Mytonomy recently deployed its virtual ...
(Date:6/11/2019)... N.C. (PRWEB) , ... June 11, 2019 , ... ... extracellular vesicles derived from human mesenchymal stem cells (MSC-EV) are able to incorporate ... cloning ability. In a test on mice, MSC-EVs also increased the cells’ ability ...
(Date:5/31/2019)... ... , ... For many years, the primary forms of cancer treatment have been ... in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) ... known as “CARs”. The CAR enables the final product to produce chemicals in the ...
Breaking Biology Technology:
Cached News: